By Drug Target Review2025-06-13T09:00:25
EPFL scientists have engineered virus-inspired DNA aptamers that bind infection targets with record selectivity. This innovation could change how we diagnose and treat infectious diseases.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
2023-05-03T15:39:23
Sponsored by BPS Bioscience
2023-09-27T10:36:50
Sponsored by NanoTemper Technologies
2023-02-07T15:25:20
Sponsored by Bio-Techne
2026-03-11T14:00:00
Sponsored by Merck
2023-07-04T10:05:58
Sponsored by Revvity
Site powered by Webvision Cloud